Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 121 AL 135

The calcium-free form of atorvastatin inhibits amyloid-β(1-42) aggregation in vitro

Nedaei H, Rezaei-Ghaleh N, Giller K, Becker S, Karami L, Moosavi-Movahedi AA, Griesinger C, Saboury AA.

J Biol Chem. 2022 Mar;298(3):101662. doi: 10.1016/j.jbc.2022.101662. Epub 2022 Jan 30.

Remote Ischemic Conditioning: A Potential Treatment for Chronic Cerebral Hypoperfusion

Ma X, Ji C.

Eur Neurol. 2022;85(4):253-259. doi: 10.1159/000521803. Epub 2022 Feb 1.

Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids

Barak M, Fedorova V, Pospisilova V, Raska J, Vochyanova S, Sedmik J, Hribkova H, Klimova H, Vanova T, Bohaciakova D.

Stem Cell Rev Rep. 2022 Feb;18(2):792-820. doi: 10.1007/s12015-021-10254-3. Epub 2022 Feb 2.

An autopsy case of Alzheimer's disease with amygdala-predominant Lewy pathology presenting with frontotemporal dementia-like psychiatric symptoms

Beck G, Shigenobu K, Ukon K, Yamashita R, Yonenobu Y, Morii E, Hasegawa M, Ikeda M, Murayama S, Mochizuki H.

Neuropathology. 2022 Apr;42(2):147-154. doi: 10.1111/neup.12786. Epub 2022 Feb 2.

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease

Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P.

J Control Release. 2022 Mar;343:528-550. doi: 10.1016/j.jconrel.2022.01.044. Epub 2022 Jan 31.

Physiology and pharmacology of amyloid precursor protein

Cho Y, Bae HG, Okun E, Arumugam TV, Jo DG.

Pharmacol Ther. 2022 Jul;235:108122. doi: 10.1016/j.pharmthera.2022.108122. Epub 2022 Feb 1.

A systematic review and meta-analysis of transcranial direct-current stimulation effects on cognitive function in patients with Alzheimer's disease

Majdi A, van Boekholdt L, Sadigh-Eteghad S, Mc Laughlin M.

Mol Psychiatry. 2022 Apr;27(4):2000-2009. doi: 10.1038/s41380-022-01444-7. Epub 2022 Feb 3.

Variant TREM2 Signaling in Alzheimer's Disease

Olufunmilayo EO, Holsinger RMD.

J Mol Biol. 2022 Apr 15;434(7):167470. doi: 10.1016/j.jmb.2022.167470. Epub 2022 Feb 1.

A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis

Shukla M, Wongchitrat P, Govitrapong P.

Neurochem Res. 2022 May;47(5):1166-1182. doi: 10.1007/s11064-022-03530-2. Epub 2022 Feb 5.

Importance of the locus coeruleus-norepinephrine system in sleep-wake regulation: Implications for aging and Alzheimer's disease

Van Egroo M, Koshmanova E, Vandewalle G, Jacobs HIL.

Sleep Med Rev. 2022 Apr;62:101592. doi: 10.1016/j.smrv.2022.101592. Epub 2022 Jan 21.

What have we learnt from past failures in Alzheimer's disease drug discovery?

Cacabelos R.

Expert Opin Drug Discov. 2022 Apr;17(4):309-323. doi: 10.1080/17460441.2022.2033724. Epub 2022 Feb 6.

Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey

DiStefano MJ, Alexander GC, Polsky D, Anderson GF.

J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.

Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings

Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M.

Biochem Pharmacol. 2022 Mar;197:114945. doi: 10.1016/j.bcp.2022.114945. Epub 2022 Feb 5.

The effects of involvement in training and volunteering with families of people with dementia on the knowledge and attitudes of volunteers towards dementia

Cheung DSK, Ho LYW, Kwok RKH, Lai DLL, Lai CKY.

BMC Public Health. 2022 Feb 8;22(1):258. doi: 10.1186/s12889-022-12687-y.

Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease

Xi M, Sun T, Chai S, Xie M, Chen S, Deng L, Du K, Shen R, Sun H.

Eur J Med Chem. 2022 Mar 15;232:114170. doi: 10.1016/j.ejmech.2022.114170. Epub 2022 Feb 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias